Clinical Trials Directory

Trials / Completed

CompletedNCT02333669

Association of SCNN1A Single Nucleotide Polymorphisms With Neonatal Respiratory Distress Syndrome

Status
Completed
Phase
Study type
Observational
Enrollment
249 (actual)
Sponsor
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University · Academic / Other
Sex
All
Age
1 Minute – 28 Days
Healthy volunteers
Accepted

Summary

Lung fluid absorption disorders are largely mediated by transepithelial Na+ reabsorption through alpha epithelial sodium channels (α-ENaCs) in alveolar epithelial cells. Increasing evidence has demonstrated that these lung disorders might be an important cause of neonatal respiratory distress syndrome (NRDS) by influencing gas exchange or surfactant function, particularly in near-term and term infants. The SCNN1A gene, which encodes the α-ENaC, might predispose infants to NRDS. To explore whether the single-nucleotide polymorphisms (SNPs) of SCNN1A are associated with NRDS, we conducted a case-control study to investigate the NRDS-associated loci in Han Chinese infants. Seven target SNPs were selected from the SCNN1A gene and were genotyped using the improved multiplex ligase detection reaction (iMLDR).

Conditions

Interventions

TypeNameDescription
OTHERno interventionno intervention

Timeline

Start date
2012-01-01
Primary completion
2014-06-01
Completion
2014-12-01
First posted
2015-01-07
Last updated
2015-01-07

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02333669. Inclusion in this directory is not an endorsement.